NCT00002337View on ClinicalTrials.gov

A Study of Multiple Doses of Vesnarinone in Advanced HIV Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Vesnarinone

Trial Locations (1)

30308

AIDS Research Consortium of Atlanta, Atlanta

Sponsors
All Listed Sponsors
lead

Otsuka America Pharmaceutical

INDUSTRY

NCT00002337 - A Study of Multiple Doses of Vesnarinone in Advanced HIV Disease | Biotech Hunter | Biotech Hunter